المؤلفون: Sylvie Le Mouhaer, Mark Clemons, Walter Jonat, Laurence Bourdeau, Barbara Pistilli, Javier Cortes, Carlos L. Arteaga, Dalila Sellami, Banu Sankaran, Yoshinori Ito, Sara A. Hurvitz, Ling Min Tseng, Seock–Ah –A Im, Ahmad Awada, José Baselga, Mona El-Hashimy, Stephen Chia, Zefei Jiang, Mario Campone, Agnieszka Jagiełło-Gruszfeld, Norikazu Masuda, Hiroji Iwata, Michele De Laurentiis

المساهمون: Campone, M., Im, S. -A., Iwata, H., Clemons, M., Ito, Y., Awada, A., Chia, S., Jagiello-Gruszfeld, A., Pistilli, B., Tseng, L. -M., Hurvitz, S., Masuda, N., Cortes, J., De Laurentiis, M., Arteaga, C. L., Jiang, Z., Jonat, W., Le Mouhaer, S., Sankaran, B., Bourdeau, L., El-Hashimy, M., Sellami, D., Baselga, J.

المصدر: European Journal of Cancer. 103:147-154

مصطلحات موضوعية: 0301 basic medicine, Oncology, Morpholine, Cancer Research, medicine.medical_specialty, Morpholines, Population, Buparlisib, Aminopyridines, Breast Neoplasms, Placebo, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Double-Blind Method, Internal medicine, Statistical significance, Antineoplastic Combined Chemotherapy Protocols, Humans, Medicine, Overall survival, education, Adverse effect, Fulvestrant, education.field_of_study, Antineoplastic Combined Chemotherapy Protocol, Hormone receptor-positive breast cancer, business.industry, Cancer, ctDNA, PIK3CA, Middle Aged, medicine.disease, Survival Analysis, Postmenopause, Aminopyridine, 030104 developmental biology, chemistry, Hormone receptor, 030220 oncology & carcinogenesis, Female, business, Breast Neoplasm, Human, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4de6dea03664991c98fc5c9f269298b4Test
https://doi.org/10.1016/j.ejca.2018.08.002Test

المؤلفون: Xavier Pivot, Michelle Miller, Seock-Ah Im, Francisco J. Esteva, Yingbo Wang, Miguel Martin, Arnd Nusch, Luis de la Cruz-Merino, Karen Rodriguez Lorenc, Patrick Neven, Dennis J. Slamon, K. Petrakova, Peter A. Fasching, J. Thaddeus Beck, Stephen Chia, Michelino De Laurentiis, Gena Vidam, Guy Jerusalem, Giulia Val Bianchi, Gabe S. Sonke, Tetiana Taran

المساهمون: Slamon, D. J., Neven, P., Chia, S., Fasching, P. A., De Laurentiis, M., Im, S. -A., Petrakova, K., Val Bianchi, G., Esteva, F. J., Martin, M., Nusch, A., Sonke, G. S., De La Cruz-Merino, L., Beck, J. T., Pivot, X., Vidam, G., Wang, Y., Lorenc, K. R., Miller, M., Taran, T., Jerusalem, G.

المصدر: Journal of Clinical Oncology. 36:2465-2472

مصطلحات موضوعية: Adult, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Receptor, ErbB-2, Aminopyridines, Anastrozole, Breast Neoplasms, Kaplan-Meier Estimate, Palbociclib, Gene mutation, 03 medical and health sciences, 0302 clinical medicine, Double-Blind Method, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Progression-free survival, Fulvestrant, Purine, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocol, business.industry, Goserelin, Middle Aged, medicine.disease, Metastatic breast cancer, Progression-Free Survival, Aminopyridine, 030104 developmental biology, Receptors, Estrogen, Purines, 030220 oncology & carcinogenesis, Hormonal therapy, Female, Receptors, Progesterone, business, Breast Neoplasm, Human, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e5fd49962d219aec82400b1e61f8756Test
https://doi.org/10.1200/jco.2018.78.9909Test